Skip to content

Clinical trials

Bronchiolitis Obliterans Syndrome trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiolitis Obliterans Syndrome Country / region: South Korea Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20072
20091
20102
20111
20134
20142
20151
20162
20174
20182
20191
20201
20212
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated4
Active, not recruiting3
Recruiting3
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals5
Pfizer4
AstraZeneca2
Pharmacyclics LLC.2
Yonsei University2
Daewoong Pharmaceutical Co. LTD.1
Ewha Womans University Mokdong Hospital1
Gilead Sciences1
GlaxoSmithKline1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiolitis Obliterans Syndrome29
Graft vs Host Disease6
Lymphoma, Follicular5
Leukemia3
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Psoriasis3
Bone Marrow Diseases2
Hematologic Diseases2
Pruritus2
Pulmonary Disease, Chronic Obstructive2

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.